Tubular breast carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Stimulant abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
3
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Attention deficit-hyperactivity
|
disease |
|
Mental or Behavioral Dysfunction
|
9
|
1
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Metabolic symptoms
|
phenotype |
|
Sign or Symptom
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hyperplastic lymph node
|
disease |
|
Acquired Abnormality
|
12
|
|
0.010 |
None |
< 0.001 |
1 |
|
1991 |
1991 |
Hypoadiponectinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
15
|
17
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adult attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
20
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Myomatous neoplasm
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
1988 |
1988 |
Asthma attack
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
32
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
High Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
1989 |
1989 |
Impulsive character (finding)
|
phenotype |
|
Mental or Behavioral Dysfunction
|
52
|
19
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Substance abuse problem
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
79
|
20
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2015 |
granulosa cell tumor
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
85
|
5
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Zinc deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
89
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
AIDS related complex
|
disease |
Infections; Immune System Diseases
|
Disease or Syndrome
|
97
|
43
|
0.010 |
None |
< 0.001 |
1 |
|
1991 |
1991 |
Substance Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
111
|
16
|
0.330 |
None |
1.000 |
3 |
1
|
2008 |
2017 |
Non-small cell lung cancer stage I
|
disease |
|
Neoplastic Process
|
115
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Linear atrophy
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
130
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
NEUROTICISM
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
141
|
50
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Bone neoplasms
|
group |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
146
|
4
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Luminal A Breast Carcinoma
|
disease |
|
Neoplastic Process
|
153
|
11
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Common Variable Immunodeficiency
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
162
|
10
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Impulsive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
163
|
59
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Invasive Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
173
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |